In our case report, we present the first case of a patient with BRAF V600E-mutated lung cancer, poor PS, acute respiratory failure, and a history of treatment for castration-resistant prostate cancer who was administered dabrafenib and trametinib. The gene discussed is BRAF; the disease is lung carcinoma.